Form 6-K Xinyuan Real Estate Co., For: Sep 22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
FOR THE MONTH OF SEPTEMBER 2023
COMMISSION FILE NUMBER: 001-33863
XINYUAN REAL ESTATE CO., LTD.
27/F, China Central Place, Tower II 79 Jianguo Road, Chaoyang District Beijing 100025 People’s Republic of China
(Address... (continue reading...)
Form 6-K Arrival For: Sep 22
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549____________________FORM 6-K____________________REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16UNDER THE SECURITIES EXCHANGE ACT OF 1934Dated September 22, 2023Commission File Number: 001-40286____________________Arrival(Translation of registrant’s name into English)60A, rue des BruyèresL-1274 Howald,Grand Duchy of Luxembourg+352 26845062(Address of principal executive... (continue reading...)
Form D/A WPG Partners Opportunist
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 8-K Magnum Opus Acquisition For: Sep 22
0001843121
false
00-0000000
0001843121
2023-09-22
2023-09-22
0001843121
OPA:ClassAordinarysharesparvalue0.0001pershareMember
2023-09-22
2023-09-22
0001843121
OPA:RedeemablewarrantseachwholewarrantexercisableforoneClassAordinaryshareMember
... (continue reading...)
Form 8-K Anterix Inc. For: Sep 21
FALSE000130449200013044922022-10-282022-10-28UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 8-KCURRENT REPORTPursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2023 Anterix Inc.(Exact name of registrant as specified in its charter)Delaware 001-36827 33-0745043(State or other jurisdiction (Commission File Number) (IRS Employerof incorporation) ... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K INTERCONTINENTAL HOTELS For: Sep 22
-
Form 8-K DIAMOND OFFSHORE DRILLIN For: Sep 21
-
Form 8-K Renalytix plc For: Sep 22
-
Form D/A BP Transtrend Diversifie
-
Form 6-K Arrival For: Sep 22
-
Form PRE 14A Edible Garden AG Inc For: Nov 06
-
Form D/A Boston Partners Portfoli
-
Form 6-K INTERCONTINENTAL HOTELS For: Sep 22
-
Form D/A Boston Partners Long/Sho
-
Form 144 Tremor International Filed by: Druker Ofer
-
Form D/A Rubrum Fund
-
Form 6-K 17 Education & Technolog For: Sep 22
-
Form D/A Pantera Venture Fund
-
Form D/A SRS Long Opportunities,
-
Form SC 13D Nano Labs Ltd Filed by: Kong Jianping
-
Form D/A SRS Long Opportunities,
-
Form SC 13D Nano Labs Ltd Filed by: Sun Qifeng
-
Form D Eunoia Capital, LLC
-
Form 144 Tremor International Filed by: Carmi Yaniv
-
Form 144 CAMTEK LTD Filed by: Stav Orit
-
Form D/A Prusik Asian Equity Inco
-
Form 8-K Cyxtera Technologies, For: Sep 21
-
Form 20-F/A Plastec Technologies, For: Dec 31
-
Form 18-K/A OESTERREICHISCHE KONTROL For: Dec 31
-
Form DEFA14A SPLUNK INC
-
Form 424B3 Aditxt, Inc.
-
Form SC 13D/A Medpace Holdings, Inc. Filed by: Troendle August J.
-
Form DEFA14A SPLUNK INC
-
Form DEFA14A SPLUNK INC
-
Form DEFA14A SPLUNK INC
-
Form 8-K U.S. Lighting Group, For: Sep 20
-
Form DEFA14A SPLUNK INC
-
Form DEFA14A SPLUNK INC
-
Form 8-K Avinger Inc For: Sep 22
-
Form 6-K Celyad Oncology SA For: Sep 22
-
Form DEFA14A SPLUNK INC
-
Form 424B3 TRANSAMERICA LIFE INSURA
-
Form 20-F/A Xinyuan Real Estate Co., For: Dec 31
-
Form DEFA14A SPLUNK INC
-
Form 8-K LiveOne, Inc. For: Sep 21
-
Form 8-K Seagen Inc. For: Sep 22
-
Form 424B5 Nikola Corp
-
Form 8-K W. P. Carey Inc. For: Sep 21
-
Form C/A Priv, Inc
-
Form S-4/A Abri SPAC I, Inc.
-
Form 8-K Cyber Apps World For: Sep 21
-
Form S-4/A Innovative International
-
Form EFFECT NaaS Technology Inc.
-
Form DEFA14A GigCapital5, Inc.
-
Form PX14A6G MEI Pharma, Inc. Filed by: Klarquist Scott
